Most Active Biotech Investors in San Carlos 2026

10 firms writing Biotech checks in San Carlos, led by Redmile Group, Sutter Hill Ventures, Abingworth — ranked by verified deal count with the companies.

Biotech in San Carlos accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $534M. The median disclosed raise is $158M, and the largest is Galvanize Therapeutics at $200M, ahead of Apexigen ($158M) and Clear Labs ($131M).

The names that recur most often on these biotech cap tables are T. Rowe Price (2 companies), Sofinnova Partners (1 company), Norwest Venture Partners (1 company), Elevage Medical Technologies (1 company), Ally Bridge Group (1 company), Perceptive Xontogeny Venture Fund (1 company). By latest disclosed round, the market skews Series C (2), Series D (1), Series B (1).

Best funded Biotech in San Carlos companies

  1. Galvanize Therapeutics — $200M (latest: Series C)
  2. Apexigen — $158M (latest: Series C)
  3. Clear Labs — $131M (latest: Series D)
  4. Glycomine — $45M (latest: Series B)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library